Meridith E. Erwin

1.0k total citations
44 papers, 887 citations indexed

About

Meridith E. Erwin is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Meridith E. Erwin has authored 44 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 20 papers in Molecular Medicine and 16 papers in Infectious Diseases. Recurrent topics in Meridith E. Erwin's work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (20 papers) and Bacterial Identification and Susceptibility Testing (13 papers). Meridith E. Erwin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (20 papers) and Bacterial Identification and Susceptibility Testing (13 papers). Meridith E. Erwin collaborates with scholars based in United States, Canada and Switzerland. Meridith E. Erwin's co-authors include Ronald N. Jones, Ronald N. Jones, Ronald N. Jones, R. J. Hollis, Hélio S. Sader, Mary S. Barrett, Steven C. Anderson, Michael A. Pfaller, David M. Johnson and Michael A. Pfaller and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

Meridith E. Erwin

43 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meridith E. Erwin United States 15 398 376 370 293 293 44 887
F. W. Goldstein France 15 277 0.7× 398 1.1× 218 0.6× 382 1.3× 214 0.7× 21 972
Matthew G. Stilwell United States 15 401 1.0× 457 1.2× 334 0.9× 270 0.9× 327 1.1× 20 1.0k
Michael A. Pfaller United States 18 299 0.8× 471 1.3× 211 0.6× 389 1.3× 316 1.1× 27 1.0k
Carmen Betriú Spain 20 323 0.8× 451 1.2× 259 0.7× 406 1.4× 331 1.1× 55 1.1k
Deborah Ashcraft United States 16 364 0.9× 379 1.0× 257 0.7× 223 0.8× 292 1.0× 30 915
Mark W. Garrison United States 15 232 0.6× 356 0.9× 298 0.8× 289 1.0× 296 1.0× 33 909
M E Erwin United States 15 303 0.8× 355 0.9× 279 0.8× 454 1.5× 159 0.5× 44 926
K. Dornbusch Sweden 16 593 1.5× 214 0.6× 306 0.8× 305 1.0× 200 0.7× 47 1.1k
Kevin W. Ward United States 13 380 1.0× 424 1.1× 258 0.7× 195 0.7× 315 1.1× 26 885
Guillermo Saurina United States 9 370 0.9× 340 0.9× 163 0.4× 212 0.7× 242 0.8× 12 803

Countries citing papers authored by Meridith E. Erwin

Since Specialization
Citations

This map shows the geographic impact of Meridith E. Erwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meridith E. Erwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meridith E. Erwin more than expected).

Fields of papers citing papers by Meridith E. Erwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meridith E. Erwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meridith E. Erwin. The network helps show where Meridith E. Erwin may publish in the future.

Co-authorship network of co-authors of Meridith E. Erwin

This figure shows the co-authorship network connecting the top 25 collaborators of Meridith E. Erwin. A scholar is included among the top collaborators of Meridith E. Erwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meridith E. Erwin. Meridith E. Erwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erwin, Meridith E., et al.. (2001). Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates. Diagnostic Microbiology and Infectious Disease. 39(2). 129–132. 2 indexed citations
2.
Jones, Ronald N., et al.. (1998). Multicenter Evaluation of the In Vitro Activity of Six Broad-Spectrum β-Lactam Antimicrobial Agents in Puerto Rico. Diagnostic Microbiology and Infectious Disease. 30(2). 113–119. 15 indexed citations
3.
Jones, Ronald N., Steven A. Marshall, Michael A. Pfaller, et al.. (1997). Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. Diagnostic Microbiology and Infectious Disease. 29(2). 95–102. 128 indexed citations
4.
Jones, Ronald N., et al.. (1995). Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United States. Diagnostic Microbiology and Infectious Disease. 21(2). 85–93. 122 indexed citations
5.
Erwin, Meridith E., et al.. (1995). Evaluation of the Etest for Determinations of Antimicrobial Spectrum and Potency Against Anaerobes Associated with Bacterial Vaginosis and Peritonitis. Clinical Infectious Diseases. 20(Supplement_2). S339–S341. 3 indexed citations
6.
Cormican, Martin, Meridith E. Erwin, & Ronald N. Jones. (1995). Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease. 22(1-2). 119–123. 8 indexed citations
7.
Sader, Hélio S., Bruce A. Runyon, Meridith E. Erwin, & Ronald N. Jones. (1995). Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis. Diagnostic Microbiology and Infectious Disease. 21(2). 105–110. 2 indexed citations
8.
Erwin, Meridith E., et al.. (1994). Cefquinome (HR 111V) in vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals. Diagnostic Microbiology and Infectious Disease. 20(1). 49–55. 46 indexed citations
9.
Jones, Ronald N., Mary S. Barrett, & Meridith E. Erwin. (1994). In-vitro activity of FK-037, a new parenteral cephalosporin. Journal of Antimicrobial Chemotherapy. 33(1). 137–144. 9 indexed citations
10.
11.
Erwin, Meridith E., et al.. (1994). Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates. Diagnostic Microbiology and Infectious Disease. 19(3). 183–186. 20 indexed citations
12.
Marshall, Steven A., Ronald N. Jones, Patrick R. Murray, et al.. (1993). In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. Journal of Antimicrobial Chemotherapy. 32(6). 877–884. 12 indexed citations
13.
Johnson, David M., Ronald N. Jones, & Meridith E. Erwin. (1993). In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones. Diagnostic Microbiology and Infectious Disease. 17(1). 79–83. 3 indexed citations
14.
Jones, Ronald N., et al.. (1993). Interlaboratory variations of fluoroquinolone susceptibility testing. Diagnostic Microbiology and Infectious Disease. 17(3). 225–232. 5 indexed citations
15.
Barrett, Mary S., Ronald N. Jones, & Meridith E. Erwin. (1993). Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae. Diagnostic Microbiology and Infectious Disease. 17(3). 243–245. 1 indexed citations
16.
Jones, Ronald N. & Meridith E. Erwin. (1992). Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin. Diagnostic Microbiology and Infectious Disease. 15(8). 693–701. 4 indexed citations
17.
Barrett, Mary S., et al.. (1991). Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628. Diagnostic Microbiology and Infectious Disease. 14(5). 389–401. 32 indexed citations
18.
Jones, Ronald N., et al.. (1991). In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). Diagnostic Microbiology and Infectious Disease. 14(5). 425–434. 30 indexed citations
19.
Jones, Ronald N., et al.. (1991). Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems. Diagnostic Microbiology and Infectious Disease. 14(4). 301–309. 6 indexed citations
20.
Jones, Ronald N., et al.. (1990). Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis group. Diagnostic Microbiology and Infectious Disease. 13(5). 371–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. W. Goldstein Breakdown of academic impact, for papers by Matthew G. Stilwell Breakdown of academic impact, for papers by Michael A. Pfaller Breakdown of academic impact, for papers by Carmen Betriú Breakdown of academic impact, for papers by Deborah Ashcraft Breakdown of academic impact, for papers by Mark W. Garrison Breakdown of academic impact, for papers by M E Erwin Breakdown of academic impact, for papers by K. Dornbusch Breakdown of academic impact, for papers by Kevin W. Ward Breakdown of academic impact, for papers by Guillermo Saurina
Rankless by CCL
2026